NAT-ABIRATERONE is a generic alternative to Zytiga^®

NAT-Abiraterone is a medication used to treat prostate cancer.

NAT-Abiraterone Program Services:

• Case management and welcome calls
• Reimbursement investigation

- Help with paperwork and navigation of coverage options through public and/or private plans

- Resolution of reimbursement issues to obtain the best possible outcome for insurance coverage

- Reimbursement appeals

• Financial assistance, compassionate use and bridging for eligible patients
• Nursing services
• Coordination with pharmacy

- Timely, secure, and complimentary delivery to a patient’s home or site of care

• Medication counselling

NAT-BOSENTAN is a generic alternative to Tracleer^®

NAT-Bosentan is a medication for treatment of pulmonary arterial hypertension (PAH, high blood pressure in the vessels that carry blood to the lungs) in adults and children 3 years of age and older.

NAT-Bosentan Program Services:

• Case management and welcome calls
• Reimbursement investigation

- Help with paperwork and navigation of coverage options through public and/or private plans

- Resolution of reimbursement issues to obtain the best possible outcome for insurance coverage

- Reimbursement appeals

• Financial assistance, compassionate use and bridging for eligible patients
• Patient compliance and adherence checks
• Pharmacy services and medication counselling
• Adverse event reporting

NAT-LENALIDOMIDE is a generic alternative to Revlimid^®

NAT-Lenalidomide is an oral medication for treatment of multiple myeloma (MM) and myelodysplastic syndrome (MDS).

NatLenAid Program Services:

• Case management and welcome calls
• Reimbursement investigation
• Financial assistance for eligible patients
• Adverse event reporting

NAT-POMALIDOMIDE is a generic alternative to Pomalyst^®

NAT-Pomalidomide (Pomalidomide) is indicated:

• in combination with Dexamethasone and Bortezomib for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior treatment regimen that included Lenalidomide.
• in combination with Dexamethasone for patients with multiple myeloma for whom both Bortezomib and Lenalidomide have failed and who have received at least two prior treatment regimens and have demonstrated disease progression on the last regimen.

NatLenAid Program Services:

• Case management and welcome calls
• Reimbursement investigation
• Financial assistance for eligible patients
• Adverse event reporting

NAT-TERIFLUNOMIDE is a generic alternative to Aubagio®

NAT-Teriflunomide is used to treat adult patients with relapsing-remitting multiple sclerosis (RRMS).

NatSupport is built to fit the needs of those affected by MS including people living with MS, their care partners, and their healthcare providers.

Our MS experienced Nurses (RNs) and Case Managers deliver first-class care and support, and build relationships with patients and healthcare professionals.

NatSupport provides answers to patients’ treatment and insurance questions.

NAT-Support Program Services:

• Case management and welcome calls
• Reimbursement investigation

- Help with paperwork and navigation of coverage options under public and/or private plans

- Resolution of reimbursement issues to obtain the best possible outcome for insurance coverage

- Reimbursement appeals

• Financial assistance, compassionate use and bridging for eligible patients
• Nursing services

- Nurse counselling & medication adherence

- Updates and feedback to your doctor about your progress

- Ongoing patient support

• Blood test reminders
• Coordination with pharmacy

- Timely, secure, and complimentary delivery to a patient’s home or site of care